Literature DB >> 27645821

The age-specific reference intervals for tPSA, fPSA, and %fPSA in healthy Han ethnic male.

Jingjing Yang1, Aiguo Tang2, Shijie Zhang1, Xiaoxu Sun1, Liang Ming1.   

Abstract

INTRODUCTION: Prostate cancer (PC) is one of the most common malignancies in male, and has become the fastest growing malignancy in recent years. Prostate specific antigen (PSA) is widely used as a tumor marker to screen for PC. Many studies have been performed to define the reference intervals (RIs) for total circulating PSA (tPSA). The results were different among different nations and races, even in the same race. Few researches have been performed on the RIs of free PSA (fPSA) and the ratio of free to total PSA (%fPSA). In this study, we aimed to simultaneously determine the age-specific RIs for tPSA, fPSA, and %fPSA in the healthy Han ethnic male.
METHODS: A total of 1862 apparently healthy male aged from 21 to 94 years were included in our study. Nonparametric 95th percentile intervals were used to define the RIs.
RESULTS: The reference limits in different age groups (21-50, 51-60, 61-70, 71-80, and ≥81 years) were 2.07, 3.59, 4.93, 6.83, and 7.73 ng/mL for tPSA, and 0.60, 0.76, 0.83, 1.30, and 2.41 ng/mL for fPSA. The RIs of %fPSA were ≥0.16 for 21-50 years and ≥0.13 for male over 50 years old.
CONCLUSIONS: We established age-specific RIs for tPSA, fPSA and %fPSA. The newly established RIs should be more suitable for Chinese Han ethnic male. It will be valuable for physicians to make exact medical decision and appropriate medical intervention.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990fPSAzzm321990; zzm321990tPSAzzm321990; %fPSA; prostate cancer; reference interval

Mesh:

Substances:

Year:  2016        PMID: 27645821      PMCID: PMC6817287          DOI: 10.1002/jcla.22062

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  18 in total

1.  The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay.

Authors:  Jingjing Yang; Mu Sa; Meng Huang; Jiajin Yang; Zhongyuan Xiang; Bo Liu; Aiguo Tang
Journal:  Clin Biochem       Date:  2013-09-06       Impact factor: 3.281

Review 2.  Prevention and early detection of prostate cancer.

Authors:  Jack Cuzick; Mangesh A Thorat; Gerald Andriole; Otis W Brawley; Powel H Brown; Zoran Culig; Rosalind A Eeles; Leslie G Ford; Freddie C Hamdy; Lars Holmberg; Dragan Ilic; Timothy J Key; Carlo La Vecchia; Hans Lilja; Michael Marberger; Frank L Meyskens; Lori M Minasian; Chris Parker; Howard L Parnes; Sven Perner; Harry Rittenhouse; Jack Schalken; Hans-Peter Schmid; Bernd J Schmitz-Dräger; Fritz H Schröder; Arnulf Stenzl; Bertrand Tombal; Timothy J Wilt; Alicja Wolk
Journal:  Lancet Oncol       Date:  2014-10       Impact factor: 41.316

Review 3.  Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer.

Authors:  Aaron M LeBeau; Maya Kostova; Charles S Craik; Samuel R Denmeade
Journal:  Biol Chem       Date:  2010-04       Impact factor: 3.915

4.  Reference intervals for serum alpha-fetoprotein and carcinoembryonic antigen in Chinese Han ethnic males from the Fangchenggang Area Male Health and Examination Survey.

Authors:  Xue Qin; Liwen Lin; Zengnan Mo; Hui Lv; Yong Gao; Aihua Tan; Xiaobo Yang; Shan Li; Jinmin Zhao
Journal:  Int J Biol Markers       Date:  2011 Jan-Mar       Impact factor: 2.659

5.  The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels.

Authors:  Alexandre E Pelzer; Hubert Volgger; Jasmin Bektic; Andreas P Berger; Peter Rehder; Georg Bartsch; Wolfgang Horninger
Journal:  BJU Int       Date:  2005-11       Impact factor: 5.588

6.  Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.

Authors:  Simon A Williams; Yi Xu; Angelo M De Marzo; John T Isaacs; Samuel R Denmeade
Journal:  Prostate       Date:  2010-05-15       Impact factor: 4.104

7.  Age-specific PSA reference ranges in Chinese men without prostate cancer.

Authors:  Zhi-Yong Liu; Ying-Hao Sun; Chuan-Liang Xu; Xu Gao; Luo-Man Zhang; Shan-Cheng Ren
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

8.  Porous silicon antibody microarrays for quantitative analysis: measurement of free and total PSA in clinical plasma samples.

Authors:  Kerstin Järås; Belinda Adler; Axel Tojo; Johan Malm; György Marko-Varga; Hans Lilja; Thomas Laurell
Journal:  Clin Chim Acta       Date:  2012-08-18       Impact factor: 3.786

9.  Age-specific reference ranges of serum prostate-specific antigen in Iraqi men.

Authors:  Marwan Hailan; Usama Nihad Rifat
Journal:  Arab J Urol       Date:  2011-12-06

10.  Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.

Authors:  Yasuhide Kitagawa; Kazuaki Machioka; Hiroshi Yaegashi; Kazufumi Nakashima; Mitsuo Ofude; Kouji Izumi; Satoru Ueno; Yoshifumi Kadono; Hiroyuki Konaka; Atsushi Mizokami; Mikio Namiki
Journal:  Asian J Androl       Date:  2014 Nov-Dec       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.